Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP844409.RAdlZtEiTH8CH1iBNJ2h8rlhnm5LbLnZfLIk_niPC0dJ8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP844409.RAdlZtEiTH8CH1iBNJ2h8rlhnm5LbLnZfLIk_niPC0dJ8130_assertion type Assertion NP844409.RAdlZtEiTH8CH1iBNJ2h8rlhnm5LbLnZfLIk_niPC0dJ8130_head.
- NP844409.RAdlZtEiTH8CH1iBNJ2h8rlhnm5LbLnZfLIk_niPC0dJ8130_assertion description "[Children with Down syndrome (DS) with acute myeloid leukemia (AML) have significantly higher event-free survival rates compared to those with non-DS AML, linked to greater cytosine arabinoside (ara-C) sensitivity and higher transcript levels of the chromosome 21-localized gene, cystathionine-beta-synthase (CBS), in DS myeloblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844409.RAdlZtEiTH8CH1iBNJ2h8rlhnm5LbLnZfLIk_niPC0dJ8130_provenance.
- NP844409.RAdlZtEiTH8CH1iBNJ2h8rlhnm5LbLnZfLIk_niPC0dJ8130_assertion evidence source_evidence_literature NP844409.RAdlZtEiTH8CH1iBNJ2h8rlhnm5LbLnZfLIk_niPC0dJ8130_provenance.
- NP844409.RAdlZtEiTH8CH1iBNJ2h8rlhnm5LbLnZfLIk_niPC0dJ8130_assertion SIO_000772 12393509 NP844409.RAdlZtEiTH8CH1iBNJ2h8rlhnm5LbLnZfLIk_niPC0dJ8130_provenance.
- NP844409.RAdlZtEiTH8CH1iBNJ2h8rlhnm5LbLnZfLIk_niPC0dJ8130_assertion wasDerivedFrom befree-20140225 NP844409.RAdlZtEiTH8CH1iBNJ2h8rlhnm5LbLnZfLIk_niPC0dJ8130_provenance.
- NP844409.RAdlZtEiTH8CH1iBNJ2h8rlhnm5LbLnZfLIk_niPC0dJ8130_assertion wasGeneratedBy ECO_0000203 NP844409.RAdlZtEiTH8CH1iBNJ2h8rlhnm5LbLnZfLIk_niPC0dJ8130_provenance.